These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 28814834)

  • 1. Intracellular trafficking of new anticancer therapeutics: antibody-drug conjugates.
    Kalim M; Chen J; Wang S; Lin C; Ullah S; Liang K; Ding Q; Chen S; Zhan J
    Drug Des Devel Ther; 2017; 11():2265-2276. PubMed ID: 28814834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-drug conjugates: an emerging modality for the treatment of cancer.
    Leal M; Sapra P; Hurvitz SA; Senter P; Wahl A; Schutten M; Shah DK; Haddish-Berhane N; Kabbarah O
    Ann N Y Acad Sci; 2014 Aug; 1321():41-54. PubMed ID: 25123209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Design of next generation antibody drug conjugates].
    Zhu GD; Fu YX
    Yao Xue Xue Bao; 2013 Jul; 48(7):1053-70. PubMed ID: 24133971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-Drug Conjugates for Cancer Therapy.
    Hafeez U; Parakh S; Gan HK; Scott AM
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33081383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fate of Antibody-Drug Conjugates in Cancer Cells.
    Chalouni C; Doll S
    J Exp Clin Cancer Res; 2018 Feb; 37(1):20. PubMed ID: 29409507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy.
    Chen H; Lin Z; Arnst KE; Miller DD; Li W
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28763044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-Drug Conjugates: The New Frontier of Chemotherapy.
    Ponziani S; Di Vittorio G; Pitari G; Cimini AM; Ardini M; Gentile R; Iacobelli S; Sala G; Capone E; Flavell DJ; Ippoliti R; Giansanti F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody drug conjugates.
    Bakhtiar R
    Biotechnol Lett; 2016 Oct; 38(10):1655-64. PubMed ID: 27334710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-targeted drugs and drug resistance--challenges and solutions.
    Shefet-Carasso L; Benhar I
    Drug Resist Updat; 2015 Jan; 18():36-46. PubMed ID: 25476546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkers Having a Crucial Role in Antibody-Drug Conjugates.
    Lu J; Jiang F; Lu A; Zhang G
    Int J Mol Sci; 2016 Apr; 17(4):561. PubMed ID: 27089329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selecting an optimal antibody for antibody-drug conjugate therapy: internalization and intracellular localization.
    Harper J; Mao S; Strout P; Kamal A
    Methods Mol Biol; 2013; 1045():41-9. PubMed ID: 23913140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-drug conjugates: Promising and efficient tools for targeted cancer therapy.
    Nasiri H; Valedkarimi Z; Aghebati-Maleki L; Majidi J
    J Cell Physiol; 2018 Sep; 233(9):6441-6457. PubMed ID: 29319167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates.
    Ritchie M; Tchistiakova L; Scott N
    MAbs; 2013; 5(1):13-21. PubMed ID: 23221464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug Conjugates.
    Caculitan NG; Dela Cruz Chuh J; Ma Y; Zhang D; Kozak KR; Liu Y; Pillow TH; Sadowsky J; Cheung TK; Phung Q; Haley B; Lee BC; Akita RW; Sliwkowski MX; Polson AG
    Cancer Res; 2017 Dec; 77(24):7027-7037. PubMed ID: 29046337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalization, Trafficking, Intracellular Processing and Actions of Antibody-Drug Conjugates.
    Xu S
    Pharm Res; 2015 Nov; 32(11):3577-83. PubMed ID: 26108878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody drug conjugates: Progress, pitfalls, and promises.
    Mukherjee A; Waters AK; Babic I; Nurmemmedov E; Glassy MC; Kesari S; Yenugonda VM
    Hum Antibodies; 2019; 27(1):53-62. PubMed ID: 30223393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics.
    Gerber HP; Koehn FE; Abraham RT
    Nat Prod Rep; 2013 May; 30(5):625-39. PubMed ID: 23525375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody Drug Conjugates for Cancer Therapy.
    Polakis P
    Pharmacol Rev; 2016 Jan; 68(1):3-19. PubMed ID: 26589413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current methods for the synthesis of homogeneous antibody-drug conjugates.
    Sochaj AM; Świderska KW; Otlewski J
    Biotechnol Adv; 2015 Nov; 33(6 Pt 1):775-84. PubMed ID: 25981886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities.
    Maiti R; Patel B; Patel N; Patel M; Patel A; Dhanesha N
    Arch Pharm Res; 2023 May; 46(5):361-388. PubMed ID: 37071273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.